IMPACT BIOMEDICAL INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation NV
Business Address 1400 BROADFIELD BLVD., HOUSTON, TX, 77084
Mailing Address 1400 BROADFIELD BLVD., HOUSTON, TX, 77084
Phone 585 232 1500
Fiscal Year End 1231
EIN 853926944
Financial Overview
FY2025
$20.29M
Total Assets
$-0.38
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 25, 2026 | View on SEC |
| 10-K Annual financial report | March 11, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 7, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 8-K Current report of material events | October 27, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | September 22, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 14, 2025 | View on SEC |
Annual Reports
10-K March 11, 2026
- Proposed reverse merger with Dr. Ashleys Limited, anticipated in early 2026, to leverage IBO's technology with global manufacturing and distribution.
- Strong intellectual property portfolio with 60 issued and over 60 pending patents, including key approvals for Laetose and 3F technologies.
Insider Trading
SELL 2 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.